Pharmaceutical risk communication: sources of uncertainty and legal tools of uncertainty management
Health Risk and Society 12 (5):453-69 (2010)
Abstract
Risk communication has been generally categorized as a warning act, which is performed in order to prevent or minimize risk. On the other side, risk analysis has also underscored the role played by information in reducing uncertainty about risk. In both approaches the safety aspects related to the protection of the right to health are on focus. However, it seems that there are cases where a risk cannot possibly be avoided or uncertainty reduced, this is for instance valid for the declaration of side effects associated with pharmaceutical products or when a decision about drug approval or retirement must be delivered on the available evidence. In these cases, risk communication seems to accomplish other tasks than preventing risk or reducing uncertainty. The present paper analyzes the legal instruments which have been developed in order to control and manage the risks related to drugs – such as the notion of “development risk” or “residual risk” – and relates them to different kinds of uncertainty. These are conceptualized as epistemic, ecological, metric, ethical, and stochastic, depending on their nature. By referring to this taxonomy, different functions of pharmaceutical risk communication are identified and connected with the legal tools of uncertainty management. The purpose is to distinguish the different functions of risk communication and make explicit their different legal nature and implications.Author's Profile
My notes
Similar books and articles
Varieties of Risk Representations.John Kadvany - 1997 - Journal of Social Philosophy 28 (3):123-143.
Antibiotic Resistance Due to Modern Agricultural Practices: An Ethical Perspective. [REVIEW]Joan Duckenfield - 2013 - Journal of Agricultural and Environmental Ethics 26 (2):333-350.
Economic (ir)rationality in risk analysis.Sven Ove Hansson - 2006 - Economics and Philosophy 22 (2):231-241.
Risk Management as a Tool for Sustainability.Frank C. Krysiak - 2009 - Journal of Business Ethics 85 (S3):483 - 492.
BSE in the UK: Why the risk communication strategy failed. [REVIEW]Karsten Klint Jensen - 2004 - Journal of Agricultural and Environmental Ethics 17 (4-5):405-423.
Risk management principles for nanotechnology.Gary E. Marchant, Douglas J. Sylvester & Kenneth W. Abbott - 2008 - NanoEthics 2 (1):43-60.
Risk Information Processing and Rational Ignoring in the Health Context.Barbara Osimani - 2012 - Journal of Socio-Economics 41:169-179.
The precautionary principle: Scientific uncertainty and omitted research in the context of GMO use and release. [REVIEW]Anne Ingeborg Myhr & Terje Traavik - 2002 - Journal of Agricultural and Environmental Ethics 15 (1):73-86.
Quantification, Regulation, and Risk Assessment.Douglas MacLean - 1982 - PSA: Proceedings of the Biennial Meeting of the Philosophy of Science Association 1982:243 - 260.
Relative uncertainty in term loan projection models: what lenders could tell risk managers.Lisa Warenski - 2012 - Journal of Experimental and Artificial Intelligence 24 (4):501-511.
Analytics
Added to PP
2012-03-28
Downloads
681 (#13,129)
6 months
36 (#36,417)
2012-03-28
Downloads
681 (#13,129)
6 months
36 (#36,417)
Historical graph of downloads
Author's Profile
Citations of this work
Scientific Evidence and the Law: An Objective Bayesian Formalisation of the Precautionary Principle in Pharmaceutical Regulation.Barbara Osimani - 2011 - Journal of Philosophy, Science and Law 11:1-24.